Plasma SFRP4 concentrations were significantly higher in patients with CAD than in those without CAD (16.8 ± 3.3 ng/mL vs 14.5 ± 2.3 ng/mL, P < 0.001). The gene discussed is SFRP4; the disease is coronary artery disorder.